The authors reply
- PMID: 38095531
- PMCID: PMC10948007
- DOI: 10.1097/CCM.0000000000006080
The authors reply
Conflict of interest statement
Drs. Lawandi, Warner, Strich, Danner, and Kadri received support for article research from the National Institutes of Health. Drs. Warner, Strich, and Danner disclosed government work. Dr. Rhee received funding from UpToDate and Cytovale. Dr. Klompas’ institution received funding from the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, and the Massachusetts Department of Public Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 U.S. Hospitals, 2008-2017.Crit Care Med. 2023 Nov 1;51(11):1527-1537. doi: 10.1097/CCM.0000000000005968. Epub 2023 Jul 3. Crit Care Med. 2023. PMID: 37395622
References
-
- Schuetz P, The Value Of A Biomarker Should Be Judged On What It Adds To The Clinical Assessment – Not The Area Under The Curve. Critical Care Medicine, 2023. In Press - PubMed
-
- Lawandi A, Bloodstream Infections in Sepsis: Better the Devil You Know*. Critical Care Medicine, 2023. 51(9): p. 1261–1263. - PubMed
-
- Kearon C, et al., Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study. BMJ, 2022. 376: p. e067378.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
